WebDisclosure WebDisclosure
Basculer en Français
10482 Companies
220830 Keywords
150169 Articles
116819 Press releases
Headlines Articles Press releases Apex Critical Metals Corp. Remove
  1. Home
  2. Companies
  3. Apex Critical Metals Corp.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/15/2024 at 15:35, 2 years ago

    Apex Critical Metals Corp. nomme Joness Lang au conseil d'administration

    Nomination Au Conseil D'administration Direction D'entreprise Options D'achat D'actions Incitatives Métaux Critiques Apex Jones Lang
  • PRESS RELEASE

    published on 05/15/2024 at 15:30, 2 years ago

    Apex Critical Metals Corp. Appoints Joness Lang to the Board of Directors

    Apex Critical Metals Corp. appoints Joness Lang, an experienced executive leader, as an independent director. Mr. Lang brings significant transaction experience to the company's board
    Stock Options Independent Director Apex Critical Metals Corp. Joness Lang Transaction Experience
    Logo of Apex Critical Metals Corp.
Previous page
1 ... 19 20
Accesswire
  • Published on 06/02/2026 at 00:00, 1 hour 4 minutes ago

    Boron One Announces Financing

  • Published on 06/01/2026 at 23:57, 1 hour 7 minutes ago

    Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million

  • Published on 06/01/2026 at 23:05, 1 hour 59 minutes ago

    Faraday Copper Strengthens Team to Support Project Advancement in Arizona

  • Published on 06/01/2026 at 23:00, 2 hours 4 minutes ago

    CCL Industries Closing of Sleever International Acquisition

  • Published on 06/01/2026 at 22:30, 2 hours 34 minutes ago

    Revolve to Present at the Small Cap Growth Virtual Investor Conference on June 4, 2026

View all ACCESSWIRE
EQS Group
  • Published on 06/01/2026 at 23:00, 2 hours 3 minutes ago

    DriveNets Secures $410M Series D to Meet Surging Demand for Ethernet Fabric in Large-Scale AI Deployments

  • Published on 06/01/2026 at 22:05, 2 hours 58 minutes ago

    EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

  • Published on 06/01/2026 at 22:05, 2 hours 59 minutes ago

    Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

  • Published on 06/01/2026 at 22:05, 2 hours 59 minutes ago

    Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

  • Published on 06/01/2026 at 21:20, 3 hours 44 minutes ago

    Eurobattery Minerals: Loft Capital exercises conversion rights – Conversion Threshold Date reached and a total of 23,798,419 new shares to be registered

View all EQS
Les Echos
  • Published on 06/01/2026 at 18:47, 6 hours 17 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 25 au 29 mai 2026

  • Published on 06/01/2026 at 18:47, 6 hours 17 minutes ago

    Disclosure of transactions in own shares from May 25 to May 29, 2026

  • Published on 06/01/2026 at 18:00, 7 hours 4 minutes ago

    Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

  • Published on 06/01/2026 at 18:00, 7 hours 4 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 06/01/2026 at 18:00, 7 hours 4 minutes ago

    Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy